May 31 |
CENTOGENE Announces Adoption of All Resolutions Tabled at 2024 Annual General Meeting
|
May 14 |
CENTOGENE and Evotec Discover Promising New Molecule to Treat Gaucher Disease
|
May 10 |
CENTOGENE Biodatabank Grows to Incorporate Disease Insights From Over 850,000 Diverse Patients
|
Apr 2 |
Centogene receives Nasdaq non-compliance letter
|
Apr 2 |
CENTOGENE Receives Nasdaq Non-Compliance Notice
|
Feb 29 |
CENTOGENE Collaborates on Research Published in Science Showing Immunopathological Landscape of Human Pre-TCRα Deficiency
|
Feb 28 |
Centogene to explores strategic alternatives, gets Nasdaq delisting notice; shares plunge
|
Feb 28 |
CENTOGENE Explores Strategic Alternatives
|
Feb 28 |
CENTOGENE Announces Receipt of Nasdaq Notice of Delisting and Intention to Request a Hearing
|
Jan 24 |
CENTOGENE Receives French Research Tax Credit Accreditation
|